Favipiravir does not appear to be a major teratogen: Case series from Türkiye

Sadeleştirilmiş öğe sayfası
dc.contributor.authorOzen, Berna
dc.contributor.authorUs, Zeynep
dc.contributor.authorToplu, Aylin
dc.contributor.authorVizdiklar, Caner
dc.contributor.authorSelalmaz, Yasemin
dc.contributor.authorCulpan, Yekta
dc.contributor.authorAsik, Zehranur Turgan
dc.contributor.authorKaskal, Mert
dc.contributor.authorAcikgoz, Busra Nazli
dc.contributor.authorOglu, Medine Gulcebi Idriz
dc.contributor.authorKaraalp, Atila
dc.contributor.authorOnat, Filiz
dc.contributor.authorYananli, Hasan Raci
dc.contributor.authorGulhan, Rezzan
dc.date.accessioned2025-10-16T15:14:09Z
dc.date.issued2024
dc.identifier.doi10.1016/j.jogoh.2023.102693
dc.identifier.otherWOS:001128584300001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6079
dc.publisherELSEVIER MASSON, CORP OFF
dc.sourceJOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
dc.subjectFavipiravir
dc.subjectPregnancy
dc.subjectCOVID\\-19
dc.subjectTeratogen
dc.subjectCongenital anomaly
dc.titleFavipiravir does not appear to be a major teratogen: Case series from Türkiye
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS